Imaqen team is very proud to announce that our research and development project, a new Method for Early Stage Breast Cancer Detection has been granted Phase 1 funding from the EU’s biggest research and innovation funding scheme instrument for Small and Medium Enterprises (SME), Horizon 2020. This funding will enable us to speed up the work to bring our groundbreaking innovation faster on the market.
Read more about the latest SME results here.
Read more about the Horizon 2020 here.
We are on a mission to save lives. Would you like to join our journey?
If you would like to learn about investment possibilities, please contact Imaqen Ltd. CEO, Mrs. Tiina Holkko, tiina.holkko (at) imaqen.com.